Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
In the latest session, Candel Therapeutics Inc (NASDAQ: CADL) closed at $6.89 down -2.41% from its previous closing price of $7.06. In other words, the price has decreased by -$2.41 from its previous closing price. On the day, 0.64 million shares were traded. CADL stock price reached its highest trading level at $7.25 during the session, while it also had its lowest trading level at $6.85.
Ratios:
For a deeper understanding of Candel Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.18 and its Current Ratio is at 1.18.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 02, 2022, initiated with a Buy rating and assigned the stock a target price of $11.
On November 19, 2021, BMO Capital Markets started tracking the stock assigning a Outperform rating and target price of $18.
On August 23, 2021, UBS started tracking the stock assigning a Buy rating and target price of $9.UBS initiated its Buy rating on August 23, 2021, with a $9 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 15 ’25 when Barone Francesca sold 13,534 shares for $7.22 per share. The transaction valued at 97,783 led to the insider holds 110,673 shares of the business.
Tyagarajan Seshu sold 14,322 shares of CADL for $103,476 on Jan 15 ’25. The Chief Technology Officer now owns 96,790 shares after completing the transaction at $7.22 per share. On Jan 15 ’25, another insider, Schoch Charles, who serves as the insider of the company, sold 9,511 shares for $7.22 each. As a result, the insider received 68,717 and left with 43,038 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CADL now has a Market Capitalization of 306436192 and an Enterprise Value of 135071536.
Stock Price History:
The Beta on a monthly basis for CADL is -1.27, which has changed by 4.601626 over the last 52 weeks, in comparison to a change of 0.23809385 over the same period for the S&P500. Over the past 52 weeks, CADL has reached a high of $14.60, while it has fallen to a 52-week low of $1.16. The 50-Day Moving Average of the stock is 5.40%, while the 200-Day Moving Average is calculated to be 2.73%.
Shares Statistics:
For the past three months, CADL has traded an average of 3.81M shares per day and 1466770 over the past ten days. A total of 44.48M shares are outstanding, with a floating share count of 32.34M. Insiders hold about 27.29% of the company’s shares, while institutions hold 16.18% stake in the company. Shares short for CADL as of 1730332800 were 1779737 with a Short Ratio of 0.80, compared to 1727654400 on 1587686. Therefore, it implies a Short% of Shares Outstanding of 1779737 and a Short% of Float of 8.06.
